Reed John C's Form 4 filing
Johnson & Johnson (JNJ) · filed Feb 18, 2026
- Accession no.
- 0000200406-26-000039
- Filed
- Feb 18, 2026
- Trade date
- Feb 15-17, 2026
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 9 non-derivative transactions and 6 derivative transactions. Open-market sales total $13.1M. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Reed John CCIK 0001181561 | Officer (EVP, Innovative Medicine, R&D) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 15, 2026 | Common Stock | MOption exerciseAcquired | +1,349 | $0.00F1 | $0 | 12,007 | Direct | |
| Feb 15, 2026 | Common Stock | FTax withholdingDisposed | −385 | $243.45 | −$93,728.25 | 11,622 | Direct | |
| Feb 15, 2026 | Common Stock | MOption exerciseAcquired | +1,847 | $0.00F3 | $0 | 13,469 | Direct | |
| Feb 15, 2026 | Common Stock | FTax withholdingDisposed | −528 | $243.45 | −$128,541.6 | 12,941 | Direct | |
| Feb 17, 2026 | Common Stock | MOption exerciseAcquired | +21,721 | $157.92 | +$3,430,180.32 | 34,662 | Direct | |
| Feb 17, 2026 | Common Stock | SSaleDisposed | −21,721 | $243.00 | −$5,278,203 | 12,941 | Direct | |
| Feb 17, 2026 | Common Stock | MOption exerciseAcquired | +29,927 | $156.15 | +$4,673,101.05 | 42,868 | Direct | |
| Feb 17, 2026 | Common Stock | SSaleDisposed | −29,927 | $243.00 | −$7,272,261 | 12,941 | Direct | |
| Feb 17, 2026 | Common Stock | SSaleDisposed | −2,283 | $243.00 | −$554,769 | 10,658 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 15, 2026 | Common Stock | MOption exerciseDisposed | −1,349 | $0.00 | $0 | 1,349 | Direct | |
| Feb 15, 2026 | Common Stock | MOption exerciseDisposed | −1,847 | $0.00 | $0 | 3,692 | Direct | |
| Feb 15, 2026 | Common Stock | AGrant or awardAcquired | +49,382 | $0.00 | $0 | 49,382 | Direct | |
| Feb 15, 2026 | Common Stock | AGrant or awardAcquired | +3,546 | $0.00 | $0 | 3,546 | Direct | |
| Feb 17, 2026 | Common Stock | MOption exerciseDisposed | −21,721 | $0.00 | $0 | 21,721 | Direct | |
| Feb 17, 2026 | Common Stock | MOption exerciseDisposed | −29,927 | $0.00 | $0 | 59,854 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting.
Referenced by the price of 1 transaction in Table I.
- F3
Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.
Referenced by the price of 1 transaction in Table I.